rs104886003
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
|
|
|
rs104886003
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs104886003
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs121913279
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913279
|
|
G |
0.710 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs121913279
|
|
G |
0.710 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913279
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs1057519925
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1057519941
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1064793732
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913272
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913272
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs121913273
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913273
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913274
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs121913274
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913281
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs121913286
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
rs121913286
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
rs121913287
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs397517201
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
PIK3CA mutation associates with improved outcome in breast cancer.
|
19671852 |
2009 |
rs397517201
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer.
|
18371219 |
2008 |
rs397517201
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs397517201
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer.
|
20177704 |
2010 |